ReviewJournal of hematology & oncology2018
BCL-2 as therapeutic target for hematological malignancies.
Guilherme Fleury Perini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
116 papers cite itlatest 60 shown
this papercites it